- Home
- EXEL vs OHI Comparison
EXEL vs OHI Comparison
Compare EXEL & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- OHI
- Stock Information
- Founded
- EXEL 1994
- OHI 1992
- Country
- EXEL United States
- OHI United States
- Employees
- EXEL N/A
- OHI N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- OHI Real Estate Investment Trusts
- Sector
- EXEL Health Care
- OHI Real Estate
- Exchange
- EXEL Nasdaq
- OHI Nasdaq
- Market Cap
- EXEL 9.7B
- OHI 10.2B
- IPO Year
- EXEL 2000
- OHI N/A
- Fundamental
- Price
- EXEL $36.20
- OHI $37.35
- Analyst Decision
- EXEL Buy
- OHI Buy
- Analyst Count
- EXEL 17
- OHI 12
- Target Price
- EXEL $35.50
- OHI $38.45
- AVG Volume (30 Days)
- EXEL 2.5M
- OHI 1.9M
- Earning Date
- EXEL 02-04-2025
- OHI 02-05-2025
- Dividend Yield
- EXEL N/A
- OHI 7.17%
- EPS Growth
- EXEL 441.02
- OHI 40.81
- EPS
- EXEL 1.55
- OHI 1.36
- Revenue
- EXEL $2,081,598,000.00
- OHI $1,011,391,000.00
- Revenue This Year
- EXEL $20.53
- OHI N/A
- Revenue Next Year
- EXEL $0.95
- OHI $9.06
- P/E Ratio
- EXEL $23.39
- OHI $27.39
- Revenue Growth
- EXEL 17.31
- OHI 18.25
- 52 Week Low
- EXEL $20.02
- OHI $27.53
- 52 Week High
- EXEL $37.59
- OHI $44.42
- Technical
- Relative Strength Index (RSI)
- EXEL 58.54
- OHI 43.09
- Support Level
- EXEL $33.05
- OHI $35.94
- Resistance Level
- EXEL $37.59
- OHI $37.96
- Average True Range (ATR)
- EXEL 0.99
- OHI 0.79
- MACD
- EXEL 0.28
- OHI 0.07
- Stochastic Oscillator
- EXEL 69.38
- OHI 56.63
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).